Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
Morgan
Sophie Victoria
SV
Department of Respiratory Medicine, St Thomas' Hospital, London, UK. sophiemorgan@doctors.org.uk
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D003657:Decision Making; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D018570:Risk Assessment; D020521:Stroke / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control; D016896:Treatment Outcome; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin